Capecitabine pharmaceutical API powder — CAS 154361-50-9 — WHO-GMP manufacturer Longshine Boi-Tech, Pune, India
Human APIs

Capecitabine

CAS Registry Number: 154361-50-9

Capecitabine — active pharmaceutical ingredient (API) manufactured to pharmacopoeial specification. Purity ≥99.0%. CAS Registry Number: 154361-50-9. Supplied in bulk quantities from $3500.00/g entry for laboratory research, analytical metho

Product information

Capecitabine — active pharmaceutical ingredient (API) manufactured to pharmacopoeial specification. Purity ≥99.0%. CAS Registry Number: 154361-50-9. Supplied in bulk quantities from $3500.00/g entry for laboratory research, analytical method development, and reference-standard applications.

Product specifications

CAS Registry Number
154361-50-9
Therapeutic Category
Human APIs
API Technology
Synthetic / Semi-synthetic (per molecule)
Development Status
Commercial — stocked
Manufacturer
Longshine Boi-Tech Pvt. Ltd.
Facility
Pune, Maharashtra, India 411001

Regulatory filings & documentation

We maintain regulatory dossiers in the following jurisdictions for Capecitabine-relevant molecules. Letter of Authorization (LoA) and CEP / DMF / ASMF references are issued at no charge to qualified buyers.

US FDA DMF (Type II)
EDQM CEP (where applicable)
Brazil ANVISA
Canada Health Canada
Japan PMDA
Korea MFDS
GCC SFDA
EU CEP
WHO-GMP & ISO 9001:2015 certified. US FDA Drug Master File available. EDQM CEP supplied for EU procurement. Pharmacopoeial release against USP, Ph. Eur., IP, JP. CoA on every batch. First-shipment lead time 7-10 business days for stocked APIs.
View interactive page & request quote Email sales Order a sample

Frequently asked questions about Capecitabine

What is Capecitabine used for?

Capecitabine is supplied as a pharmaceutical-grade human apis for use by regulated pharmaceutical manufacturers, contract development and manufacturing organisations (CDMOs), and research institutions. Buyers using Capecitabine typically reference it under CAS Registry Number 154361-50-9.

What quality and regulatory standards does Longshine Boi-Tech's Capecitabine meet?

Our Capecitabine is manufactured under WHO-GMP and ISO 9001:2015 conditions in Pune, India. Per-batch Certificate of Analysis (CoA) is released against USP / Ph. Eur. / IP / JP specifications depending on destination market. We hold US FDA Drug Master File and EDQM Certificate of Suitability dossiers for the molecules where regulatory recognition is required; Letter of Authorization (LoA) is issued at no charge to qualified buyers.

How do I request a quote, sample, or proforma invoice for Capecitabine?

Quote requests for Capecitabine are turned around within 24 business hours (IST, Pune). Bulk APIs typically ship within 7-10 business days of confirmed PO; air freight to North America and Europe runs 4-5 days door-to-door. Sample agreements are signed before shipping QC-grade material to your formulation laboratory.

Which countries does Longshine Boi-Tech supply Capecitabine to?

We export Capecitabine to 50+ countries including the United States, Canada, Mexico, Brazil, the European Union, the United Kingdom, Japan, Australia, South Korea, the GCC and across South-East Asia. All regulatory documents (DMF / CEP / LoA) and shipping incoterms (EXW, FCA, CIP, DAP, DDP) are negotiated per buyer.

Related Human APIs APIs

Other human apis molecules from Longshine Boi-Tech's WHO-GMP catalogue — each with active regulatory filings, audit-ready CoA, and samples available under CDA.

Trametinib
CAS 871700-17-3
Abiraterone Acetate
CAS 154229-18-2
Emtricitabine
CAS 143491-57-0
Valacyclovir HCl
CAS 124832-27-5
Topotecan HCl
CAS 119413-54-6
Quetiapine Fumarate
CAS 111974-72-2
Tamsulosin HCl
CAS 106463-17-6
Vildagliptin
CAS 274901-16-5

Related categories & resources

Browse the full Human APIs catalogue or all 560+ products. Reference documents: certifications portfolio · quality system · FDA DMF buyer guide · EU CEP supplier guide · complete product index.